Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Jessie Barra has received the prestigious NIH K99/R00 award to study immune cell survival in type 1 diabetes, focusing on innovative human-cell system approaches to understand how harmful immune cells escape elimination and contribute to disease development. Jessie Barra has…
Oneness Biotech’s experimental siRNA drug SNS851 advances to the next phase of testing, focusing on its safety and effectiveness for fatty liver disease, with initial results anticipated in early 2027. Oneness Biotech has said its experimental obesity drug SNS851 has…
With rising risks associated with low and high blood sugar levels, medical specialists underscore the importance of precise management strategies, including the proven 15-15 rule, to prevent life-threatening episodes among diabetics. Low blood sugar can become dangerous quickly for people…
A new indirect comparison presented at the European Association for the Study of Diabetes suggests that Lilly’s oral GLP-1 drug Foundayo may deliver greater weight loss and improved blood sugar control than a higher-dose regimen of oral semaglutide, signalling a…
The US Food and Drug Administration has yet to update prescribing labels for widely used GLP-1 drugs despite overseas regulators warning of a rare but serious risk of vision loss, highlighting inconsistencies in global safety responses. The US Food and…
With more than a third of deaths in Mexico linked to high cholesterol, diabetes and hypertension often co-occur, prompting calls for integrated prevention and treatment strategies to combat rising cardiovascular and kidney failure risks. High cholesterol, uncontrolled blood sugar and…
Diabetes Meal Plans launches a new weekly menu featuring meat-free, lower-carbohydrate dishes with personalised options, combining practical support tools to help individuals with type 2 diabetes and prediabetes manage their condition more effectively. Diabetes Meal Plans has published its latest…
Regenxbio reports promising three-year follow-up data for its innovative single-dose gene therapy targeting diabetic retinopathy, highlighting sustained efficacy and safety, as it advances to larger clinical trials. REGENXBIO has reported new three-year follow-up data suggesting that its single-dose gene therapy…
People with diabetes face increasing danger from hypoglycaemia unawareness, a condition where warning signs diminish, raising the risk of severe complications. Experts emphasise the importance of regular testing to prevent emergencies and long-term health issues. People with diabetes may sometimes…
Austria is harnessing its pharmacy network to boost early detection of heart disease and diabetes, aligning with EU efforts to increase prevention awareness amid a global focus on cardiovascular health. Pharmacies across Austria are being promoted as an accessible first…
A large US study indicates that stopping and restarting GLP-1 receptor agonists like semaglutide diminishes their cardiovascular benefits for type 2 diabetes patients, with risks increasing the longer treatment is interrupted. A large study of more than 330,000 people with…
A new Healthians report analysing over 1.6 million HbA1c tests highlights a significant increase in abnormal blood sugar readings in India, with notable regional and age-related variations, reflecting the growing diabetes challenge amid complex testing patterns. Healthians’ latest testing data…
